
Are you crazy?


Marijuana legalization was a clear winner in the November election, as one in three Americans will now live in a state with legal marijuana. In red states like Montana and South Dakota; swing states like Arizona; and blue states like New Jersey, marijuana legalization ballot measures were extremely successful, in many cases at levels approaching supermajorities. In every single one of these states–from red to blue, east to west, urban to rural–marijuana legalization far outperformed the states’ Democratic tickets.
In my state of California, voters overwhelmingly passed Proposition 64 in 2016, which legalized marijuana use. Following its passage, marijuana arrests decreased by 56%, demonstrating the power decriminalization has to curb mass incarceration.
None of this should come as a surprise. We knew the popularity of marijuana legalization and the MORE Act long before November 3rd. Support for these policies has been steadily rising since the 1970s. This summer, polling from Data for Progress and the Justice Collaborative Institute found that when asked about its specific provisions, 59 percent of voters, including a majority of Republicans, support the MORE Act.


Two Canadian researchers think that a special strain of cannabis might potentially be a valuable tool in the fight against COVID-19.
The researchers, Olga and Igor Kovalchuck have reportedly been developing and testing a novel cannabis strain for years, except with the goal of creating a strain that helps to combat cancer and inflammation. When the pandemic hit, the duo started to focus their efforts on how the strain might be used to help fight COVID-19.
The duo’s work was published in an April issue of the online medical journal Preprints.
“Similar to other respiratory pathogens, SARS-CoV2 is transmitted through respiratory droplets, with potential for aerosol and contact spread. It uses receptor-mediated entry into the human host via angiotensin-converting enzyme II (ACE2) that is expressed in lung tissue, as well as oral and nasal mucosa, kidney, testes, and the gastrointestinal tract,” reads the study. “Modulation of ACE2 levels in these gateway tissues may prove a plausible strategy for decreasing disease susceptibility.”
After looking at the research done on cannabis and COVID by other scientists, they were able to determine that cannabis, a special strain in particular, could potentially block COVID-19 from entering a person’s body to begin with.
It all comes down to our body’s ACE2 receptors, which works sort of like doorways into our bodies for the virus. In the case of the Kovalchuck’s work, cannabis would be used to decrease the level of ACE2 gene expression, essentially temporarily closing the doors to the virus.





You must be logged in to post a comment.